Back to search

Article

“Hyper-Hypermethylated Status” of the MGMT Gene Promoter Confers Additional Survival Benefits in IDH-Wild-Type Glioblastoma Patients

2021-02-09

Abstract excerpt

<title>Abstract</title> <p>IntroductionMethylation status of the O(6)-Methylguanine-DNA methyltransferase (<italic>MGMT</italic>) promoter plays key role in glioblastoma (GBM) with respect to the patient’s responses to temozolomide chemotherapy and disease prognosis. Although the cut-off value of <italic>MGMT</italic> methylation (≥10%) is currently widely used to dichotomize the<italic> MGMT </italic>status as “...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1fc08531-bdcb-567e-b02b-01392e663ecd
DOI
10.21203/rs.3.rs-178009/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
“Hyper-Hypermethylated Status” of the MGMT Gene Promoter Confers Additional Survival Benefits in IDH-Wild-Type Glioblastoma PatientsDOI 10.21203/rs.3.rs-178009/v1
Select a neighboring publication to make it the new centre.